2) oxidant concentration reduction
降低氧化物浓度
4) Drug concentration
药物浓度
1.
AIM To establish a simple and practical method for the estimation of the inter-patient variability of cytochrome P450(CYP3A)enzyme activity and to predict drug concentration and parmacokinetics of etoposide with the variability of CYP3A in chidren patients with leukemia.
方法采用HPLC测定药物浓度,一点法计算药物消除半衰期,尿样法测定体内CYP3A酶活性。
2.
Objective: To establish a HPLC method for the determination of the drug concentration in bile after the injection of lomefloxacine.
目的:建立用HPLC方法测定注射洛美沙星后不同时间的胆汁药物浓度。
3.
It was found that SM2 was absorbed quickly and distributed widely, the concentrations in the tissues of heart, liver, lung, kidney and small intestine were all higher,facially, the drug concentration in the tissue of small intestine was highest.
５ｈ药物浓度高达２７。
5) plasma concentration
药物浓度
1.
Association between valproic acid plasma concentration and CYP2C19 gene ploymorphism;
丙戊酸药物浓度与 CYP2C19 基因多态性关系的研究
6) chemotherapeutic agents
化疗药物
1.
Isolation and purification of breast cancer stem cells by suspension culture combined with chemotherapeutic agents;
悬浮培养联合化疗药物筛选乳腺癌干细胞
2.
Apoptosis of neuroblastoma cells induced by a combination of tumor necrosis factor-related apoptosis-inducing ligand and chemotherapeutic agents;
TRAIL联合化疗药物诱导神经母细胞瘤细胞凋亡的研究
3.
Objective To elucidate the relationship between apoptosis in vitro induced by chemotherapeutic agents and its clinical significance in primary acute leukemia(AL).
目的 研究化疗药物体外诱导原代急性白血病 (AL)细胞凋亡与临床疗效的关系。
补充资料：卵巢癌单一药物化疗
卵巢癌单一药物化疗
卵巢上皮癌的单一药物化疗，仅用一种药物进行化疗。由于其效果不如联合化疗，故目前已较少采用。但因其用法简单，宜于较长时间在门诊治疗，故多用于早期病例术后的巩固治疗，或用于因其他并发症，无法耐受联合化疗者。常用药物①马利兰(Melphalan)0.2mg/(kg·d)，5天为1个疗程，间隔3～4周；②塞替派(Thiotepa)20mg加生理盐水20ml，静推，隔日1次，共8次，总量160mg；或40mg＋生理盐水300ml，腹腔注射，每周2次，总量200mg，均间隔4周；③六甲嘧胺(hexamethylmelamine,HMM)200～250mg/m2，连续2周，或8mg/kg·d，连服3个月，间隔4周。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条